Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.
Mark Matthews sees risk of 20% market correction in 2025, warns valuations are high
We have not reduced our own risk in our portfolios. But we are suspecting that at some point this year, there will be a reason